Connect with us
As part of the transaction, Galapagos will also transfer to Alfasigma the European and U.K. marketing authorizations and related commercial, medical, and development activities, as well...
In short, the watch launched by Durcal acts as a solution for elderly people who live alone and are not considering moving to a residence. In...
Novartis has acquired global rights to develop, manufacture, and commercialize Leqvio under a licensing and collaboration agreement with Alnylam Pharmaceuticals, which is a leader in RNA...
PharmaMar wanted to highlight the growth in royalty income, which has increased by 8% compared to the same period of the previous year, reaching a total...
The agreement between the two companies allows Debiopharm to access licensing options to continue the development of SunRock Biopharma's antibodies, integrating Debiopharm's innovative conjugation technologies, called...
Almirall is a global biopharmaceutical company focused on medical dermatology. We collaborate with scientists and healthcare professionals to address patient needs through science to improve their...
The Viennese biotech company has developed a type of vaccine based on genetically modified arenaviruses. In the case of HB-200, these are vectors based on the...
Euroespes was listed on BME Growth for twelve years, but because of its entry into bankruptcy proceedings, the regulator has suspended its listing. Before the suspension,...
The agreement signed between Microsoft and Ribera also involves collaboration with Futurs, the technological subsidiary of the Ribera Group, which thus becomes a partner of the...
Almirall will obtain a license to use EpimAb's patented Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform. The Spanish pharmaceutical company reduced its profit by 56% in the first half...
 |
|
 |  |
 |
|